Development and Validation of a Brief Self-Report Scale to Measure Perceived Immune Vulnerability (PIV) in Cancer Population.

Saved in:
Bibliographic Details
Title: Development and Validation of a Brief Self-Report Scale to Measure Perceived Immune Vulnerability (PIV) in Cancer Population.
Authors: Sun L; Oncology Department, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.; Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Fok RW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore 168583, Singapore., Bawa J; Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Li X; Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Lampson K; Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Chimonas S; Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Atkinson TM; Psychiatry and Behavioural Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Mao JJ; Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Source: Cancers [Cancers (Basel)] 2025 Nov 20; Vol. 17 (22). Date of Electronic Publication: 2025 Nov 20.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2072-6694
DOI:10.3390/cancers17223713